Company Comparison
Nurix Therapeutics vs AI Therapeutics
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Nurix Therapeutics | AI Therapeutics |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | — | San Diego |
| Founded | — | — |
| Status | Active | Active |
| Last Funding Stage | — | Series A |
| Total Funding | — | $48M |
| Valuation | — | — |
What They Build
Nurix Therapeutics
A clinical-stage biopharmaceutical company developing precision medicines using targeted protein degradation technology for cancer and inflammatory diseases.
AI Therapeutics
A San Diego biotech company using AI to accelerate drug discovery and development processes.
Key Investors
Nurix Therapeutics
AI Therapeutics
No investors listed.
Sector Overlap
Both Nurix Therapeutics and AI Therapeutics operate in Biotech.
Browse all Biotech companies →Websites
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
Now in alpha with select funds. 14-day trial available.